NOACs Linked to Slower Cognitive Decline in Patients With A-Fib, Alzheimer Disease

FRIDAY, Sept. 4, 2026-- For patients with atrial fibrillation (AF) and Alzheimer disease (AD), non-vitamin K oral anticoagulants (NOACs) are associated with modestly slower cognitive decline, according to a study published online Aug. 12 in the...